Community/Retail

This will be the third collaboration between Pfizer and BioNTech in the infectious diseases field, following the influenza vaccine collaboration in 2018 and the COVID-19 vaccine collaboration in 2020.

There were no instances of participants withdrawing from the study due to an adverse event caused by psilocybin in the treatment of mental health conditions.

GeneSight Mental Health Monitor finds that many struggle to know the difference between teenage behavior and a mental health challenge.

Results of a separate analysis demonstrate that Johnson & Johnson’s booster generated a 41-fold increase in neutralizing antibodies and a 5-fold increase in T-cells against omicron.

The drug is made from Ananda’s Liquid Structure technology that creates new potential for cannabidiol therapeutics, such as facilitating voluntary opioid sparing.

Alyson McGregor, MD, of Brown University explains what pharmacists can do to advance issues arising around the impact of sex and gender on medicine.

Xlear treats sinus pressure and congestion caused by colds, flu, allergies, pollen, and post-nasal drip.

Anifrolumab-fnia is a human immunoglobulin G (IgG)1κ monoclonal antibody indicated for the treatment of moderate to severe systemic lupus erythematosus.

Generalized anxiety disorder has symptoms that are similar to panic disorder, obsessive-compulsive disorder, and other types of anxiety.

In laboratory molecular tests, scientists mix samples with assay reagents in a highly controlled process, but because the reaction conditions are tightly controlled, the tests are both sensitive and selective, according to the researchers.

Pay for outcomes is here to stay, but are pharmacy claims an outdated source of quality measurement?

These lumps can relate to the overproduction of hormones, including the stress steroid hormone cortisol, which can lead to T2D and high blood pressure.

Rebecca Sleeper, PharmD, FCCP, FASCP, BCPS, of the Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, discusses how a lack of sex and gender specific patient care education can impact a pharmacist’s work with their patients.

Tixagevimab co-packaged with cilgavimab is one of the only 2 antibody therapies issued emergency use authorization by the FDA that showed neutralizing activity against omicron and all other variants of concern.

A survey was administered electronically to key kidney care stakeholders in 182 International Society of Nephrology (ISN)-affiliated countries, with 88% responding and 97% answering the survey items related to kidney nutrition care.

The results of an analysis from investigators from Baylor College of Medicine suggest that supplementation with GlyNAC might be beneficial to those who have the virus.

Alyson McGregor, MD, of Brown University discusses the focus of her research into sex and gender in emergency medicine.

Arnicare temporarily relieves muscle pain and relieves stiffness due to minor injuries.

The efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors.

In patients with gastroparesis, the stomach's motility is slowed down or doesn't work at all, preventing proper emptying.

The approval marks the first small interfering RNA therapy for low-density lipoprotein cholesterol reduction.

Eli Lilly says the drug in combination with TCS also achieved all key secondary endpoints versus the placebo for individuals with AD.

1960-2021

The study analyzed blood samples taken from individuals infected with COVID-19, those who had been vaccinated with a 2-dose schedule and a third booster dose, and those who had reported previous infection from other COVID-19 variants of concern.

This is an update to the 2011 AAN guideline on the treatment of painful diabetic neuropathy, according to a press release.

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.

The existing EUA was also amended to reduce the time for booster dose administration from a minimum of 6 months to at least 5 months following completion of the primary COVID-19 vaccine series.

Pharmacists can play a key role in providing education and guidance to patients with glaucoma.